These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8946598)

  • 1. [Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia].
    Bargetzi MJ; Tichelli A; Gratwohl A; Speck B
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1944-5. PubMed ID: 8946598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
    Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Kreze O
    Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV
    Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [All-trans retinoic acid-induced erythema nodosum in acute promyelocytic leukemia].
    Taguchi A; Takahashi T; Harima Y; Takemoto Y; Ando T; Nomiyama J; Matsubara A; Yujiri T; Tanizawa Y
    Rinsho Ketsueki; 2005 Mar; 46(3):202-5. PubMed ID: 16447715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital.
    da Costa Moraes CA; Trompieri NM; Cavalcante Felix FH
    J Pediatr Hematol Oncol; 2008 May; 30(5):387-90. PubMed ID: 18458575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
    Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
    Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute promyelocytic leukemia: experience with trans-retinoic acid in Argentina].
    Nucifora E; Fantl D; Goldstein S; Kusminsky G
    Medicina (B Aires); 1996; 56(4):333-8. PubMed ID: 9138336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All- trans-retinoic acid-induced erythema nodosum in patients with acute promyelocytic leukemia.
    Kuo MC; Dunn P; Wu JH; Shih LY
    Ann Hematol; 2004 Jun; 83(6):376-80. PubMed ID: 14648024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A third complete remission of acute promyelocytic leukemia achieved by administering a gradual increase of all-trans retinoic acid following massive ascites due to retinoic acid syndrome].
    Tsujioka T; Wada H; Yata K; Suemori S; Yamada O; Sugihara T
    Rinsho Ketsueki; 2003 Jul; 44(7):474-6. PubMed ID: 12931568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scrotum exfoliative dermatitis with ulcers associated with treatment of acute promyelocytic leukemia with all-trans retinoic acid].
    Tajima K; Sagae M; Yahagi A; Akiba J; Suzuki K; Hayashi T; Satoh S
    Rinsho Ketsueki; 1998 Jan; 39(1):48-52. PubMed ID: 9492553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.